Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Proceeds will be used to advance the development of three Zentalis-discovered oncology clinical candidates as well as business development for future pipeline additions in China.
Zentera Therapeutics (Shanghai) Co., Ltd. successful hold investigator meeting for c3ZTCN100
This meeting was attended by investigators from seven clinical sites, officers from site institutions and stakeholders from relevant vendors.
Zentera Therapeutics Shanghai Co., Ltd. successful hold investigator meeting for c5ZTCN100
That meeting was face to face and virtual, which was strongly supported and participated by investigators, GCP officer of each site and management team of vendors.
Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint...
Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint Venture.
©2021 - Zentera正腾康版权所有